title: Intraprostatic injection therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia.
authors.forename: Christopher
authors.initials: C
authors.lastname: Chapple
mesh_terms: D001427:Bacterial Toxins / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D006801:Humans; D007267:Injections; D008297:Male; D010410:Penile Erection / Q000187:drug effects; D052899:Pore Forming Cytotoxic Proteins / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D017430:Prostate-Specific Antigen / Q000097:blood; D011470:Prostatic Hyperplasia / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D011788:Quality of Life; D012720:Severity of Illness Index; D013997:Time Factors; D016896:Treatment Outcome; D014563:Urodynamics / Q000187:drug effects; D014570:Urologic Diseases / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology
chemical_list: D001427:Bacterial Toxins; C518473:PRX302; D052899:Pore Forming Cytotoxic Proteins; D017430:Prostate-Specific Antigen